ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

January 22, 1999

In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13

April 10, 1981

Radiotherapy Wing Contractor Dropped

March 27, 1981

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

October 23, 1998

Blood Vessel Growth Inhibitor May Be Tested Against KS

August 16, 1991